A case of recurrent IgG4-related disease successfully treated with ...
2022年10月6日 · A case of recurrent IgG4-related disease successfully treated with belimumab after remission of systemic lupus erythematosus Rheumatology (Oxford) . 2022 Oct …
贝利尤单抗治疗风湿性疾病临床研究进展 - 汉斯出版社
贝利尤单抗是一种重组人源化的IgG1-λ单克隆抗体，特异性识别B淋巴细胞刺激因子 (B lymphocyte stimulator, BLyS)并阻断其与B淋巴细胞受体结合，从而抑制反应性B淋巴细胞的存活，诱导凋 …
case of recurrent IgG4-related disease successfully treated with ...
2022年5月20日 · Therefore, this is the first case that IgG4-RD is successfully treated with belimumab, which is a recombinant human IgG-1λ monoclonal antibody that inhibits BAFF, …
An overlapping case of IgG4-related disease and systemic lupus
2024年1月4日 · Recently, belimumab, a recombinant human IgG-1λ monoclonal antibody that inhibits B-cell activating factor, was approved, but reports of use for IgG4-RD are scarce. …
An overlapping case of IgG4-related disease and systemic lupus ...
2024年1月3日 · Recently, belimumab, a recombinant human IgG-1λ monoclonal antibody that inhibits B-cell activating factor, was approved, but reports of use for IgG4-RD are scarce. …
Our case and the literature review summarize reported rare overlapping cases of IgG4-RD and SLE and suggest that belimumab is a promising candidate for the treatment of IgG4-RD. IgG4 …
A case with good response to belimumab for lupus nephritis
Immunoglobulin (Ig)G4-related disease (IgG4-RD) is an unusual complication of systemic lupus erythematosus (SLE). We report a case in which belimumab proved efficacious for not only …
An overlapping case of IgG4-related disease and systemic lupus ...
2024年1月3日 · Recently, belimumab, a recombinant human IgG-1λ monoclonal antibody that inhibits B-cell activating factor, was approved, but reports of use for IgG4-RD are scarce. …
Immunoglobulin (Ig)G4-related disease (IgG4-RD) is an unusual complication of systemic lupus erythematosus (SLE). We report a case in which belimumab proved efficacious for not only …
A case with good response to belimumab for lupus nephritis complicated ...
2019年3月27日 · Immunoglobulin (Ig)G4-related disease (IgG4-RD) is an unusual complication of systemic lupus erythematosus (SLE). We report a case in which belimumab proved efficacious …